Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Raquel Lopez Reyes (Torrent (Valencia), Spain), Raquel Lopez-Reyes, Alberto Garcia-Ortega, Enrique Zaldivar, Miguel Perpiña Tordera. Calv,NO and J’awNO in asthma. A multidimensional approach. Eur Respir J 2015; 46: Suppl. 59, 2098

Member's Comments

No comment yet.

Related content which might interest you: Evaluation of inflammatory markers IL-6 and MMP-9 in asthma Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms Year: 2015 U-BIOPRED asthma cohort: Inflammatory markers and corticosteroid use Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Induced sputum lipid mediators in severe asthma Source: International Congress 2016 – Translational studies in lung disease Year: 2016 The multicomponent nature of difficult asthma Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Pharmacogenetics in severity of bronchial hyperresponsiveness in asthma Source: Annual Congress 2013 –Genetic factors in airway development and disease Year: 2013 Psychophysiology of depression in bronchial asthma Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 Lung function, FEno, symptoms and obesity in asthma – A cross-sectional study Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality Year: 2016 Phenotypic characteristics of asthma with small airways involvement Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 Clinical application of hydrogen sulfide (H2S) as a marker of asthma management Source: International Congress 2016 – Asthma points to ponder Year: 2016 Meta-analysis of the accuracy of screening adult asthma using exhaled nitric oxide Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Combination of elevated exhaled nitric oxide and serum eosinophil cationic protein identifies asthma patients at risk for exacerbation Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Clinical outcomes in non-eosinophilic versus eosinophilic asthma after 12 months specialist management Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease Year: 2015 Associated factors with persistent airflow limitation in asthma in U-BIOPRED Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Study of the small airway and its role in pediatric asthma control assessment Source: International Congress 2015 – Paediatric asthma and allergy: asthma management Year: 2015 Concomitant use of fractional exhaled nitric oxide (FeNO) and asthma control test (ACT) as markers for predicting asthma exacerbation Source: International Congress 2014 – Asthma: clinical problems Year: 2014 Priorities for asthma R&D in Europe: A systematic approach Source: International Congress 2016 – Asthma points to ponder Year: 2016 Validation of ATS guidelines for FeNO to monitor eosinophillic airway inflammation Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Treating peripheral eosinophilia in asthma: Simple and effective Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Reactive oxygen metabolite levels are surrogate biomarkers for predicting exacerbation of bronchial asthma Source: International Congress 2016 – Systemic biomarkers Year: 2016 Further evidence that FeNO directed therapy reduces asthma exacerbations Source: International Congress 2014 – Airway biomarkers Year: 2014